TSS
SRRA

Two Sigma Securities’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Two Sigma Securities’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-331
Closed -$20K – 1182
2016
Q4 		$20K Buy
331
+10
+3% +$623 0.01% 653
2016
Q3 		$23K Buy
+321
New +$24.8K 0.01% 596

Other funds holding SRRA

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Two Sigma Securities's SRRA Position: Q1 2017 in Review

Two Sigma Securities sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q1 2017, closing a stake of 331 shares — an estimated $20K sold.

Two Sigma Securities first reported a position in SRRA in Q3 2016 and held it in 2 quarters. The position peaked at $23K in Q3 2016. 44 funds tracked by Wall St. Rank hold SRRA as of Q1 2017.

  • Two Sigma Securities reported no remaining Sierra Oncology, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
  • Two Sigma Securities sold 331 Sierra Oncology, Inc. Common Stock shares in Q1 2017, an estimated $20K.
  • Two Sigma Securities first reported a position in Sierra Oncology, Inc. Common Stock in Q3 2016 and held it in 2 quarters.
  • Two Sigma Securities's Sierra Oncology, Inc. Common Stock position peaked at $23K in Q3 2016.
  • 44 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q1 2017.

Based on Two Sigma Securities's 13F filing for Q1 2017, filed 15 May 2017.